Back to search

Netherlands· NL-a63d175ca91f

Suvexx 85 mg/500 mg filmomhulde tabletten

A sumatriptan and naproxen product containing naproxennatrium + sumatriptansuccinaat, registered in Netherlands by Orion Corporation. The same ATC class is registered in 8 of our 19 countries.

ATC N02CC51

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSuvexx 85 mg/500 mg filmomhulde table…ATCN02CC51REGISTER NO.NL-a63d175ca91fPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Sumatriptan and naproxen is registered in 8 of 19 countries.

Countries holding a registration under ATC N02CC51 (sumatriptan and naproxen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose

Sumatriptan and naproxen · ATC N02CC51

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NAPROXENNATRIUM + SUMATRIPTANSUCCINAAT
Manufacturer
Orion Corporation
Country
Netherlands (NL)
ATC code
N02CC51
ATC class
Sumatriptan and naproxen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132188

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sumatriptan and naproxen in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sumatriptan and naproxen products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Sumanet
  • Belgium · Migsun
  • Czechia · Frimig Duo
  • Germany · Suvexx
  • Denmark · Nomigrin
  • Estonia · Migsun
  • Spain · Suvexx
  • Finland · Nomigrin
  • France · Nomanesit
  • United Kingdom (Northern Ireland) · Suvexx
  • Greece · Suvexx
  • Hungary · Nomigrin
  • Ireland · Migsun
  • Italy · Sumanet
  • Lithuania · Migsun
  • Latvia · Migsun
  • Norway · Nomigrin
  • Poland · Frimig Duo
  • Portugal · Suvexx
  • Sweden · Nomigrin
  • Slovakia · Frimig Duo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/330c78ef-9386-4ae9-9c52-a16b900bca9b
GET /v1/drugs/330c78ef-9386-4ae9-9c52-a16b900bca9b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132188_smpc.pdf",
  "strength": null,
  "atc_label": "Sumatriptan and Naproxen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132188",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
    "POVIDON K 30 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "NAPROXENNATRIUM",
    "SUMATRIPTANSUCCINAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132188.pdf",
  "authorised_at": "2024/06/04",
  "procedure_number": "FI/H/1108/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132188",
  "additional_monitoring": "N"
}

See everything about sumatriptan and naproxen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.